Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection.

Simple Summary: Ovarian cancer is one of the deadliest gynecologic cancers, largely due to the difficulty of detecting it early. Current screening methods, such as CA125 blood tests and ultrasound, lack accuracy, while advanced genetic tests are costly and impractical for widespread use. This study...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 17; no. 7; pp. 1251 - 1264
Autores principales: Ahn, Eunyong, Kim, Se Ik, Park, Sungmin, Kim, Sarah, Kim, Hyunjung, Lee, Hyejin, Kim, Heeyeon, Song, Eun Ji, Ahn, TaeJin, Song, Yong-Sang
Formato: equations & formulas research tables/charts Journal Article
Publicado: MDPI Apr2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184443357&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184443357
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Apr2025
      vid: 17
      iid: 7
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        184443357
        184443357
        184443357
        10.3390/cancers17071251
        184443357
      ppf: 1251
      ppct: 13
      formats:
      tig:
        atl: Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection.
      aug:
        au:
          Ahn, Eunyong
          Kim, Se Ik
          Park, Sungmin
          Kim, Sarah
          Kim, Hyunjung
          Lee, Hyejin
          Kim, Heeyeon
          Song, Eun Ji
          Ahn, TaeJin
          Song, Yong-Sang
        affil: Foretell My Health, Inc. 558 Handong-ro Buk-gu, Pohang 37554, Republic of Korea
      sug:
        subj:
          Polymerase Chain Reaction Economics
          Algorithms
          Blood Platelets
          RNA Analysis
          Sensitivity and Specificity
          Cost Effectiveness Analysis
          Ovarian Neoplasms Diagnosis
          Neoplasms, Cystic, Mucinous, and Serous Diagnosis
          Early Detection of Cancer
          Neoplasm Grading
          Human
          Funding Source
          Cancer Patients
          Sequence Analysis
          Tumor Markers, Biological
          Gene Expression
          Descriptive Statistics
          Inflammation
          Female
          Female
      ab: Simple Summary: Ovarian cancer is one of the deadliest gynecologic cancers, largely due to the difficulty of detecting it early. Current screening methods, such as CA125 blood tests and ultrasound, lack accuracy, while advanced genetic tests are costly and impractical for widespread use. This study aims to develop a cost-effective and accessible diagnostic method using qPCR-based platelet RNA profiling to detect ovarian cancer earlier, particularly the aggressive high-grade serous ovarian cancer (HGSOC). By analyzing blood samples, we identified RNA-based biomarkers that can differentiate ovarian cancer from benign conditions with over 94% accuracy. These findings suggest that platelet RNA biomarkers could improve early detection, potentially leading to better survival rates. This research contributes to the advancement of liquid biopsy diagnostics, offering a promising alternative to current screening approaches. Background/Objectives: Ovarian cancer (OC) remains one of the most lethal gynecologic malignancies, largely due to the challenges of early detection. While next-generation sequencing (NGS) has been explored for screening, its high cost limits large-scale implementation. To develop a more accessible diagnostic solution, we designed a qPCR-based algorithm optimized for early OC detection, with a focus on high-grade serous ovarian cancer (HGSOC), the most aggressive subtype. Methods: Peripheral blood samples from 19 ovarian cancer patients, 37 benign tumor patients, and 34 asymptomatic controls were analyzed using RNA sequencing to identify splice junction-based biomarkers with minimal expression in benign samples but elevated in OC. Results: A final panel of 10 markers was validated via qPCR, demonstrating strong agreement with sequencing data (R2 = 0.44–0.98). The classification algorithm achieved 94.1% sensitivity and 94.4% specificity (AUC = 0.933). Conclusions: By leveraging platelet RNA profiling, this approach offers high specificity, accessibility, and potential for early OC detection. Future studies will focus on expanding histologic diversity and refining biomarker panels to further enhance diagnostic performance.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N